21 January 2015
Advanced Medical Solutions Group plc
(“AMS” or the “Group”)
Notice of Preliminary Results
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the surgical and advanced woundcare specialist company, will announce its unaudited preliminary results for the year ended 31 December 2014 on Wednesday 4 March 2015.
A briefing for analysts will be held at 10:00am on the day of the results. Please contact Consilium Strategic Communications for further details.
– Ends –
For further information, please visit www.admedsol.com or contact:
|
Advanced Medical Solutions Group plc Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director
|
+44 (0) 1606 545508 |
|
Consilium Strategic Communications Mary-Jane Elliot / Jonathan Birt / Matthew Neal / Ivar Milligan
|
+44 (0) 20 3709 5700 AMS@consilium-comms.com |
|
Investec Bank plc (NOMAD & Broker) Gary Clarence / Daniel Adams / Patrick Robb |
+44 (0) 20 7597 5970 |
About Advanced Medical Solutions Group plc – see www.admedsol.com
Founded in 1991, AMS is a leader in the development and manufacture of innovative and technologically advanced products for the US$20 billion global wound care and wound closure market. AMS has a wide range of products based on technologies that include alginates, silver alginates, foams, collagens, cyanoacrylate adhesives and sutures.
AMS manufactures wound care products for an extensive list of Original Equipment Manufacturer (“OEM”) customers around the world, but the majority of the Group’s revenues now come from its own brands – ActivHeal® wound care products in the UK to the NHS, LiquiBand® cyanoacrylate products primarily in the UK, Europe and the USA, and RESORBA® sutures and haemostat products primarily in Europe. AMS develops innovative products from its R&D pipeline which it commercialises globally, either directly or through partnerships with its OEM customers.
AMS’s products are sold globally via a network of regional or multinational partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.
With 465 employees operating under four distinct business units (Branded Direct, Branded Distributed, OEM and Bulk Materials) that match its multiple products and routes-to-market, AMS’s products are manufactured from two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic.
This information is provided by RNS
END
NOREASFEAFKSEFF